A study published in "Nature" shows the mRNA vaccine could extend the lives of people undergoing cancer treatment.
GlobalData on MSN
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure
While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...
Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback